Ranbaxy Laboratories in talks to source ingredients for generic Nexium: Report

12 Mar 2014 Evaluate

Ranbaxy Laboratories is reportedly in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc’s heartburn drug Nexium, after a US ban on shipments from a plant in India. Nexium had global sales last year of $3.87 billion.

Earlier in January, Washington prohibited Ranbaxy, from selling drugs in the United States using ingredients from one of its plants in northern India due to poor manufacturing practices.

Ranbaxy Laboratories is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×